About us
Pipeline
Target Markets
Our Technology
Partnering
News, Media & Events
- News
- Media
- Events
Careers
Contact

Home
News, Media & Events
Media Coverage
Destiny Pharma CSO discusses breakthrough treatment for C. difficile infection

Destiny Pharma CSO discusses breakthrough treatment for C. difficile infection

Email us

25 Old Burlington Street
Level 2
London
United Kingdom
W1S 3A

Registered Company No. 16638547

About us
Pipeline
Target Markets
Our Technology
Partnering
News, Media & Events
Careers
Contact

Registered Company No. 3167025

Terms of Use
Privacy Statement

About us
Pipeline
Target Markets
Our Technology
Partnering
News, Media & Events
News
Media
Events
Careers
Contact